Firm begins study of sepsis detection device

09/12/2013 | MassDevice.com (Boston)

T2 Biosystems has kicked off a clinical study of its T2Candida test, which is used to detect a fungus often linked to hospital-acquired infections that can trigger sepsis. Data from the trial will be used to support the company's regulatory application for the assay, which takes just about three hours to spot a single colony-forming unit of the Candida fungus in a 1-milliliter blood sample.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC